Back
Denali Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
DNLI
Sponsored
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
29
DNLI
Denali Therapeutics
Last Price:
16.83
Seasonality Move:
-0.16%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.Denali Therapeutics Price Quote
$16.83
+0.68 (+4.21%)
(Updated: May 2, 2024 at 3:45 PM ET)
Denali Therapeutics Key Stats
Sell
29
Denali Therapeutics (DNLI)
is a Sell
Day range:
$15.40 - $16.72
52-week range:
$14.56 - $33.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.56
P/B ratio:
2.23%
Volume:
971.7K
Avg. volume:
1.1M
1-year change:
-37.4%
Market cap:
$2.3B
Revenue:
$330.5M
EPS:
$-1.08
How Much Does Denali Therapeutics Make?
Data Unavailable
Is Denali Therapeutics Growing As A Company?
Data Unavailable
Denali Therapeutics Stock Price Performance
-
Did Denali Therapeutics Stock Go Up Last Month?
Denali Therapeutics share price went down by -21.45% last month -
Did DNLI's Share Price Rise Over The Last Year?
DNLI share price fell by -37.4% over the past 1 year
What Is Denali Therapeutics 52-Week High & Low?
-
What Is Denali Therapeutics’s 52-Week High Share Price?
Denali Therapeutics has traded as high as $33.31 over the past 52 weeks -
What Is Denali Therapeutics’s 52-Week Low Share Price?
Denali Therapeutics has traded as low as $14.56 over the past 52 weeks
Denali Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Denali Therapeutics?
-
How Much Debt Does Denali Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Denali Therapeutics Have?
Cash and short term investments quarterly total is $1B -
What Is Denali Therapeutics’s Book Value Per Share?
Book value per share is 7.45
Is Denali Therapeutics Cash Flow Positive?
-
What Is DNLI Cash Flow From Operations?
Cash flow from operations (TTM) is -$358M -
What Is Denali Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $17.8M -
What Is Denali Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $249.3M
Denali Therapeutics Return On Invested Capital
Data Unavailable
Denali Therapeutics Earnings Date & Stock Price
-
What Is Denali Therapeutics's Stock Price Today?
A single share of DNLI can be purchased today for 16.15 -
What Is Denali Therapeutics’s Stock Symbol?
Denali Therapeutics trades on the nasdaq under the ticker symbol: DNLI -
When Is Denali Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Denali Therapeutics is scheduled on May 8, 2024 -
When Is DNLI's next ex-dividend date?
Denali Therapeutics's next ex-dividend date is May 2, 2024 -
How To Buy Denali Therapeutics Stock?
You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Denali Therapeutics Competitors
-
Who Are Denali Therapeutics's Competitors?
Below is a list of companies who compete with Denali Therapeutics or are related in some way:
Denali Therapeutics Dividend Yield
Data Unavailable
Denali Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -10.08% |
Revenue: | 0% | -100% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 40.27 |
Upside from Last Price: | 149.33% |